Keurig Dr Pepper price target raised to $36 from $32 at Barclays

Barclays raised the firm’s price target on Keurig Dr Pepper to $36 from $32 and keeps an Overweight rating on the shares ahead of the Q1 report. In consumer health products and beverages, investors are starting to look beyond the expensive high-visibility names for more value-oriented opportunities, the analyst tells investors in a research note. Meanwhile, in food, the firm wouldn’t be surprised to see more “second derivative” share reactions to Q1 upside versus “admittedly very subdued expectations.”